Evidence map›Paper›PMID 25349204›Full record

ArticleJournal of the American Society of Nephrology : JASN2015

Effect of Genetic African Ancestry on eGFR and Kidney Disease.

Miriam S Udler, Girish N Nadkarni, Gillian Belbin, Vaneet Lotay, Christina Wyatt, Omri Gottesman, Erwin P Bottinger, Eimear E Kenny, Inga Peter

Abstract readComparative Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Structured Application of Genetic Testing in a Pediatric Kidney Clinic.Journal of the American Society of Nephrology : JASN · 2026
    Article
  7. Article
  8. African ancestry-enriched variants in themedRxiv : the preprint server for health sciences · 2025
    Article
  9. Review
  10. Article
  11. Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in 2 multiethnic urban cohorts.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2024
    Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miriam S UdlerDepartments of Medicine and Genetics and Genomic Sciences, The Charles Bronfman Institute for Personalized Medicine, mudler@mgh.harvard.edu.
Girish N NadkarniDepartments of Medicine and The Charles Bronfman Institute for Personalized Medicine, Division of Nephrology.
Gillian BelbinGenetics and Genomic Sciences, The Charles Bronfman Institute for Personalized Medicine.
Vaneet LotayThe Charles Bronfman Institute for Personalized Medicine.
Christina WyattDepartments of Medicine and Division of Nephrology.
Omri GottesmanDepartments of Medicine and The Charles Bronfman Institute for Personalized Medicine.
Erwin P BottingerDepartments of Medicine and The Charles Bronfman Institute for Personalized Medicine, Division of Nephrology.
Eimear E KennyGenetics and Genomic Sciences, The Charles Bronfman Institute for Personalized Medicine, The Center for Statistical Genetics, and The Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York.
Inga PeterGenetics and Genomic Sciences, The Charles Bronfman Institute for Personalized Medicine, The Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, New York.

Funding

TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
Glomerular Cell-Cell Crosstalk and InjuryR01DK097253 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAEHN, ILSE SOFIA · 2013 to 2025
$7.3M
eMERGE Coordinating Center - Administrative SupplementU01HG006385 · NHGRI · VANDERBILT UNIVERSITY · PI HARRIS, PAUL A. · 2011 to 2014
$5.4M
Biorepository for Genomic Medicine in diverse CommunitiesU01HG006380 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOTTINGER, ERWIN P. · 2011 to 2015
$4.5M
Geisinger eGenonic Medicine (GeM) ProgramU01HG006382 · NHGRI · GEISINGER CLINIC · PI CAREY, DAVID J., WILLIAMS, MARC S. · 2011 to 2014
$4.3M
A Personalized Genomic Medicine Pilot Program Using the NJgene eMERGE ExperienceU01HG006388 · NHGRI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHISHOLM, REX L, SMITH, MAUREEN E · 2011 to 2014
$4.1M
IRIS: Incorporating Research Into SightU01HG006389 · NHGRI · ESSENTIA INSTITUTE OF RURAL HEALTH · PI MCCARTY, CATHERINE ANNE · 2011 to 2014
$4.1M
Genetic Discovery and Application in a Clinical Setting Continuing a PartnershipU01HG006375 · NHGRI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI JARVIK, GAIL PAIRITZ, LARSON, ERIC B · 2011 to 2014
$4.1M
Vanderbilt Genome Electronic Records ProjectU01HG006378 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2011 to 2014
$4.0M
Better Outcomes for Children: GWAS & PheWAS in eMERGEII.U01HG006828 · NHGRI · CINCINNATI CHILDRENS HOSP MED CTR · PI HARLEY, JOHN BARKER, HOLM, INGRID ADELE · 2012 to 2014
$4.0M
Mount Sinai Nephrology Research Training GrantT32DK007757 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CAMPBELL, KIRK N, HE, JOHN CIJIANG · 1998 to 2022
$3.8M
NHGRI NIH HHS U01 HG006375NHGRI NIH HHS U01-HG006375NHGRI NIH HHS U01 HG006378NHGRI NIH HHS U01-HG006378NHGRI NIH HHS U01 HG006379NHGRI NIH HHS U01-HG006379NHGRI NIH HHS U01 HG006380NHGRI NIH HHS U01-HG006380NHGRI NIH HHS U01 HG006382NHGRI NIH HHS U01-HG006382NHGRI NIH HHS U01 HG006385NHGRI NIH HHS U01-HG006385NHGRI NIH HHS U01 HG006388NHGRI NIH HHS U01 HG006389NHGRI NIH HHS U01-HG006389NHGRI NIH HHS U01 HG006828NHGRI NIH HHS U01-HG006828NHGRI NIH HHS U01 HG006830NHGRI NIH HHS U01-HG006830NHGRI NIH HHS UH0HG006830NIDDK NIH HHS R01 DK097253NIDDK NIH HHS T32 DK007028NIDDK NIH HHS T32 DK007757
6 · The paper itself

Abstract

Self-reported ancestry, genetically determined ancestry, and APOL1 polymorphisms are associated with variation in kidney function and related disease risk, but the relative importance of these factors remains unclear. We estimated the global proportion of African ancestry for 9048 individuals at Mount Sinai Medical Center in Manhattan (3189 African Americans, 1721 European Americans, and 4138 Hispanic/Latino Americans by self-report) using genome-wide genotype data. CKD-EPI eGFR and genotypes of three APOL1 coding variants were available. In admixed African Americans and Hispanic/Latino Americans, serum creatinine values increased as African ancestry increased (per 10% increase in African ancestry, creatinine values increased 1% in African Americans and 0.9% in Hispanic/Latino Americans; P≤1x10(-7)). eGFR was likewise significantly associated with African genetic ancestry in both populations. In contrast, APOL1 risk haplotypes were significantly associated with CKD, eGFR<45 ml/min per 1.73 m(2), and ESRD, with effects increasing with worsening disease states and the contribution of genetic African ancestry decreasing in parallel. Using genetic ancestry in the eGFR equation to reclassify patients as black on the basis of ≥50% African ancestry resulted in higher eGFR for 14.7% of Hispanic/Latino Americans and lower eGFR for 4.1% of African Americans, affecting CKD staging in 4.3% and 1% of participants, respectively. Reclassified individuals had electrolyte values consistent with their newly assigned CKD stage. In summary, proportion of African ancestry was significantly associated with normal-range creatinine and eGFR, whereas APOL1 risk haplotypes drove the associations with CKD. Recalculation of eGFR on the basis of genetic ancestry affected CKD staging and warrants additional investigation.

Indexed as

Genetic VariationAgedAge DistributionApolipoprotein L1ApolipoproteinsBlack or African AmericanBlack PeopleCohort StudiesDatabases, FactualFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGlomerular Filtration RateHispanic or LatinoHumansIncidenceAPOL1 protein, humanApolipoprotein L1ApolipoproteinsLipoproteins, HDLapolipoprotein L1epidemiology and outcomesethnicitygenetic renal diseaseGFRrenal function

Identifiers

PMID25349204
PMCPMC4483587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.